Ligand Pharma share price logo

Ligand Pharma

NASDAQ: LGND

$286.32

-3.42

(-1.18%)

as on

Ligand Pharma Stock Performance

as on September 5, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $285.86
    $290.00
    downward going graph

    0.16%

    Downside

    1.29%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $161.82
    $326.63
    downward going graph

    43.48%

    Downside

    14.08%

    Upside

    downward going graph

Ligand Pharma share price movements today

Previous Close
$289.74
Open
$288.42
Volume
136.0K
Market Cap
$5.7B
Day's Low - High
$285.86 - $290.00
52 Week Low - High
$161.82 - $326.63

Ligand Pharma Historical Returns

1 Month Return
-3.67 %
3 Month Return
+ 22.82 %
1 Year Return
+ 72.73 %
3 Year Return
+ 335.44 %
5 Year Return
+ 109.65 %

Ligand Pharma Stock Fundamentals & Key Indicators

Check Ligand Pharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$5.7B

EPS (TTM)

10.01

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

8.25%

PE Ratio (TTM)

28.95

Industry PE ratio

-13.53

PEG Ratio

0.029280785599881454

EBITDA

273.7M

Revenue (TTM)

290.5M

Profit Margin

98.58%

Return On Equity TTM

20.06%

Ligand Pharma Stock Valuation

Track how Ligand Pharma P/E has moved over time to understand its valuation trends.

Ligand Pharma in the last 5 years

  • Overview

  • Trends

Lowest (-487.05x)

December 31, 2024

Industry (-13.53x)

December 31, 2025

Today (29.36x)

December 31, 2025

Highest (44.96x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: 29.36x

Ligand Pharma vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Ligand Pharma with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$5.7B109.65%28.9598.58%NA
BUY$44.6B614.61%NA0.00%NA
BUY$141.1B181.73%32.2186.04%NA
BUY$60.2B-64.27%-18.66-12.57%NA
BUY$84.8B24.12%20.1484.86%0.44%

Stock Returns calculator for Ligand Pharma Stock including INR - Dollar returns

The Ligand Pharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Ligand Pharma investment value today

Current value as on today

₹1,82,871

Returns

₹82,871

(+82.87%)

Returns from Ligand Pharma Stock

₹70,693 (+70.69%)

Dollar Impact

₹12,178 (+12.18%)

Analyst Recommendation on Ligand Pharma Stock

Based on 8 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 8 analysts, 100% of analysts recommend a 'BUY' rating for Ligand Pharma. Average target price of $342.82

Ligand Pharma Share Price Target

Get share price movements and forecasts by analysts on Ligand Pharma.

What analysts predicted

16.48%UPSIDE

Target Price

$342.82

Current Price

$286.32

Analyzed by

8 Analysts

Target

$342.82

Ligand Pharma target price $342.82, a slight upside of 16.48% compared to current price of $286.32. According to 8 analysts rating.

Indian Investors' Interest in Ligand Pharma Stock

Search interest for Ligand Pharma Stock has decreased by -54% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-54% versus previous 30 day period

Ligand Pharma Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
30
41
51
42
45
47
115
59
51
63
Gross Profit
19
56
39
39
40
44
90
85
49
60
Operating Income
2
-19
3
-9
-36
8
54
20
17
8
EBITDA
122
-55
3
-29
-40
20
149
66
-14
72
Interest Expense
0
1
0
0
0
1
0
1
1
1
Depreciation
8
8
8
8
8
8
8
9
8
8
Income Before Tax
113
-65
-6
-39
-50
11
141
56
-24
64
Income Tax Expense
27
-13
0
-8
-7
6
23
11
-10
15
Net Income
86
-51
-7
-31
-42
4
117
44
-13
48
Net Profit Margin
64.27%
136.90%
75.88%
93.37%
89.30%
93.90%
78.50%
143.56%
95.99%
94.95%

Ligand Pharma Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
141
251
120
163
241
196
131
167
268
Gross Profit
135
245
108
133
179
143
96
156
261
Operating Income
68
163
807
37
103
3
11
-22
47
EBITDA
81
238
876
56
142
81
100
40
192
Interest Expense
11
48
35
27
19
1
0
3
4
Depreciation
12
16
43
27
50
43
36
35
33
Income Before Tax
57
173
796
1
72
36
63
2
158
Income Tax Expense
44
30
167
-5
-4
41
9
6
34
Net Income
12
143
629
-2
57
-33
52
-4
124
Net Profit Margin
96.20%
97.48%
90.57%
81.40%
74.26%
73.08%
73.31%
93.37%
97.54%

Ligand Pharma Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
86
-51
-7
-31
-42
4
117
44
-13
48
Operating Cash Flow
18
13
36
28
-25
15
13
45
48
24
Investing Cash Flow
-3
-54
-46
-38
4
-10
-353
-18
-94
321
Financing Cash Flow
12
9
55
20
-4
14
409
8
-14
546
Change in Cash
27
-31
45
8
-24
19
71
35
-59
891

Ligand Pharma Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
12
143
629
-2
57
-33
52
-4
124
Operating Cash Flow
93
194
-29
54
78
137
49
97
49
Investing Cash Flow
-84
-423
466
231
30
163
-11
-143
-377
Financing Cash Flow
-7
328
-485
-310
-137
-275
-59
97
428
Change in Cash
1
99
-47
-24
-28
25
-22
49
102

Mutual Funds that own Ligand Pharma Stock

Check out the Mutual Funds with significant holdings in Ligand Pharma.

Funds
Holdings
Shares Held
Delaware Group Equity Funds V
8.083439%
1611483
VANGUARD INDEX FUNDS
7.623388%
1519769
JANUS INVESTMENT FUND
3.88885%
775266
Franklin Custodian Funds
2.633478%
525000
Fidelity Securities Fund
1.959634%
390665

Global Institutional Holdings in Ligand Pharma

Funds
Holdings
iShares
11.91%
Vanguard
9.3%
SPDR
2.14%
Invesco
1.66%
Dimensional
0.98%

Ligand Pharma News & Key Events

    Insights on Ligand Pharma

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Profit Spike

      img

      Netprofit is up for the last 2 quarters, -13.34M → 48.50M (in $), with an average increase of 127.5% per quarter

    • imgPOSITIVE IMPACT

      Price Rise

      img

      In the last 3 years, LGND stock has moved up by 335.4%

    • imgPOSITIVE IMPACT

      Revenue Rich

      img

      Revenue is up for the last 2 quarters, 51.72M → 63.69M (in $), with an average increase of 18.8% per quarter

    • imgPOSITIVE IMPACT

      Best in 3 Years

      img

      In the last 3 years, LGND has outperformed top 5 stocks with highest market-cap in its industry

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Moderna, Inc. Common Stock has given 513.1% return, outperforming this stock by 440.4%

    About Ligand Pharma

    Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
    OrganisationLigand Pharma
    Headquarters555 Heritage Drive, Jupiter, FL, United States, 33458
    IndustryBiotechnology
    CEOMr. Todd C. Davis Ph.D.
    E-voting on sharesClick here to vote

    Key Management of Ligand Pharma

    Name

    Title

    Mr. Todd C. Davis Ph.D.

    CEO & Director

    Mr. Octavio Espinoza

    Chief Financial Officer

    Mr. Andrew T. Reardon J.D.

    Chief Legal Officer & Secretary

    Ms. Marjorie Fackovec

    Head of People Operations

    Dr. Keith Marschke Ph.D.

    Senior Vice President of Biology & Scientific Affairs

    Dr. Vincent D. Antle Ph.D.

    Senior Vice President of Technical Operations & QA - Capitsol

    Mr. Paul J. Hadden

    Senior Vice President of Investments & Business Development

    Ms. Melanie J. Herman CPA

    Executive Director of Investor Relations and Financial Planning & Analysis

    Dr. Karen R. Reeves M.D.

    Senior VP of Investments & Head of Clinical Strategy

    Mr. Richard B. Baxter

    Senior VP of Investment Operations

    FAQs

    What is Ligand Pharma share price today?

    Ligand Pharma share price today is $286.32 as on at the close of the market. Ligand Pharma share today touched a day high of $290.00 and a low of $285.86.

    What is the 52 week high and 52 week low for Ligand Pharma share?

    Ligand Pharma share touched a 52 week high of $326.63 on and a 52 week low of $161.82 on . Ligand Pharma stock price today i.e. is closed at $286.32,which is 12.34% down from its 52 week high and 76.94% up from its 52 week low.

    What is Ligand Pharma's market capitalisation today?

    Ligand Pharma market capitalisation is $0.01T as on .

    How to invest in Ligand Pharma Stock (LGND) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Ligand Pharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ligand Pharma Shares that will get you 0.0052 shares as per Ligand Pharma share price of $286.32 per share as on September 5, 2026 at 1:29 am IST.

    What is the minimum amount required to buy Ligand Pharma Stock (LGND) from India?

    Indian investors can start investing in Ligand Pharma (LGND) shares with as little as ₹94.485 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹944.85 in Ligand Pharma stock (as per the Rupee-Dollar exchange rate as on ). Based on Ligand Pharma share’s latest price of $286.32 as on September 5, 2026 at 1:29 am IST, you will get 0.0349 shares of Ligand Pharma. Learn more about fractional shares .

    What are the returns that Ligand Pharma has given to Indian investors in the last 5 years?

    Ligand Pharma stock has given 109.65% share price returns and 29.94% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?